We are designing an easy-to-use, handheld device to diagnose COVID-19 and provide automated data tracking for accurate reporting.
OmniVis’ hardware device and single use disposable test kit (razor/razorblade model) attaches to a smartphone and reduces the detection process down to 30 minutes, accurately and affordably. Additionally, OmniVis’ data gathering & reporting tools provide insights over disease hotspots; enabling earlier warning before wide scale outbreaks occur.
What is the need are you focusing on?
Running tests on the OmniVis platform.
COVID-19 is spreading at an uncontrollable rate, causing an unforeseen pandemic. It is difficult to diagnose as patients oftentimes remain asymptomatic for up to 2 weeks post-exposure. COVID-19 symptoms are not unique, mimicking flu-like symptoms such as fever, chest cough, and fatigue. Access to diagnostics is strained, exacerbating the problem. Without widespread testing, COVID-19 continues to disproportionately affect our elderly populations with 93% of deaths occurring in just 4 countries.
We are focusing our efforts on translating our rapid diagnostic device toward the detection of COVID-19 from nasopharyngeal swabs. Our intention is for the device to be distributed for use to medical care facilities for rapid diagnosis and automated record keeping, providing more accurate reporting of COVID-19 cases. The affordability and accessibility of our device will address the issue of rapid disease spread by providing a versatile solution that can be administered on a global scale.